Market Tracker

01/29 11:19am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.61
Data as of 11:03am ET
 -0.06 / -0.69%
Today’s Change
7.09
Today|||52-Week Range
11.47
+3.73%
Year-to-Date

Today’s Trading

Previous close8.67
Today’s open8.66
Day’s range8.60 - 8.81
Volume33,409
Average volume (3 months)404,807
Market cap$364.0M
Dividend yield--
Data as of 11:03am ET, 01/29/2015

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+103.44%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.13

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...-0.70-4.31%
DRNADicerna Pharmaceutic...-0.05-0.24%
SCLNSciClone Pharmaceuti...+0.20+2.70%
CCXIChemoCentryx Inc+0.19+2.11%
Data as of 11:18am ET, 01/29/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts